AM
AVeta provides hormone-free treatments for vaginal atrophy using scientifically validated methods that target the physiological changes associated with this condition. The company offers safe and affordable solutions that enhance vaginal health and improve the quality of life for individuals experiencing discomfort.
Updated 4 months ago
Funding
$323.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- AVeta provides hormone-free treatments for vaginal atrophy using scientifically validated methods that target the physiological changes associated with this condition. The company offers safe and affordable solutions that enhance vaginal health and improve the quality of life for individuals experiencing discomfort.